
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.29.21 Amidst Prolonged Downtrend
2025-11-26 09:49:59Vivo Bio Tech . has reached a new 52-week low of Rs.29.21 today, marking a significant decline amid a sustained period of negative returns. The stock has been on a downward trajectory for the past ten trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.29.21 Amidst Continued Downtrend
2025-11-26 09:49:58Vivo Bio Tech . has reached a fresh 52-week low of Rs.29.21 today, marking a significant decline amid a sustained downward trend that has persisted over the past ten trading sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing challenges within the company’s financial and operational metrics.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:47:03Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant milestone in its ongoing downward trajectory. The stock has been on a losing streak for eight consecutive trading sessions, reflecting a cumulative return decline of 10.85% over this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:52Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid an extended period of negative returns. The stock has recorded losses over the past eight consecutive trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:51Shares of Vivo Bio Tech . touched a fresh 52-week low of Rs.30.11 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has been under pressure, reflecting a series of financial and market factors that have influenced its performance over the past year.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:51Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past eight consecutive trading sessions, reflecting a cumulative return of -10.85% during this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:42Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant milestone in its recent price movement. The stock has been on a downward trajectory for eight consecutive trading sessions, reflecting a cumulative return decline of 10.85% during this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:40Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid an extended period of negative returns. The stock has been trading below all major moving averages and has recorded losses over the past eight consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Vivo Bio Tech . Stock Hits 52-Week Low at Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:36Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant point in its recent trading performance. The stock has been on a downward trajectory for eight consecutive sessions, reflecting a cumulative return decline of 10.85% over this period, while underperforming its sector by 0.29% today.
Read MoreBoard Meeting Intimation for Meeting To Be Held On Friday February 13 2026
02-Feb-2026 | Source : BSEVivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
16-Jan-2026 | Source : BSEplease find enclosed
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
09-Jan-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kompella Lopa Mudra
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available